| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |